SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001439222-21-000064
Filing Date
2021-07-29
Accepted
2021-07-29 10:56:36
Documents
65
Period of Report
2021-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q agio-20210630.htm   iXBRL 10-Q 1589403
2 EX-31.1 exhibit31-1x06x30x21.htm EX-31.1 9841
3 EX-31.2 exhibit31-2x06x30x21.htm EX-31.2 9860
4 EX-32.1 exhibit32-1x06x30x21.htm EX-32.1 4833
5 EX-32.2 exhibit32-2x06x30x21.htm EX-32.2 4836
  Complete submission text file 0001439222-21-000064.txt   6623212

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT agio-20210630.xsd EX-101.SCH 35168
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT agio-20210630_cal.xml EX-101.CAL 83453
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT agio-20210630_def.xml EX-101.DEF 203646
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT agio-20210630_lab.xml EX-101.LAB 514628
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT agio-20210630_pre.xml EX-101.PRE 367531
11 EXTRACTED XBRL INSTANCE DOCUMENT agio-20210630_htm.xml XML 1109723
Mailing Address 88 SIDNEY STREET CAMBRIDGE MA 02139
Business Address 88 SIDNEY STREET CAMBRIDGE MA 02139 617-649-8600
AGIOS PHARMACEUTICALS, INC. (Filer) CIK: 0001439222 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36014 | Film No.: 211125673
SIC: 2834 Pharmaceutical Preparations